1. Volume 144, Issue 5, Pages 933-944 (May 2013)
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment 
Grace Lai–Hung Wong, Henry Lik–Yuen Chan, Hoi–Yun Chan, Pete Chi–Hang Tse, Yee–Kit Tse, Christy Wing–Hin Mak, Stanley King– Yeung Lee, Zoe Man–Yi Ip, Andrew Ting–Ho Lam, Henry Wing–Hang Iu, Joyce May–Sum Leung, Vincent Wai–Sun Wong 
Gastroenterology 
Volume 144, Issue 5, Pages (May 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
The AUCs of CU-HCC, GAG-HCC, and REACH-B scores at (A) baseline and (B) 2 years to predict HCC.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier analysis of the cumulative incidence of HCC in patients according to (A) CU-HCC scores at baseline and 2 years: <5 at baseline, ≥5 at baseline and <5 at 2-year score, and ≥5 at both time points (overall comparison, P = .006); (B) GAG-HCC scores at baseline and 2 years: <101 at baseline, ≥101 at baseline and <101 at 2-year score, and ≥101 at both time points (overall comparison, P < .001); and (C) REACH-B scores at baseline and 2 years: <8 at baseline and/or 2 years (referent) and ≥8 at both time points (P = .056).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions